Evidence map›Paper›PMID 31978078›Full record

ArticlePloS one2020

Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice.

Mariana Angoa-Pérez, Branislava Zagorac, Andrew D Winters, Jonathan M Greenberg, Madison Ahmad, Kevin R Theis, Donald M Kuhn

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Science signaling · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mariana Angoa-PérezResearch and Development Service, John D. Dingell VA Medical Center, Detroit, Michigan, United States of America.
Branislava ZagoracResearch and Development Service, John D. Dingell VA Medical Center, Detroit, Michigan, United States of America.
Andrew D WintersDepartment of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
Jonathan M GreenbergDepartment of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
Madison AhmadDepartment of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
Kevin R TheisDepartment of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
Donald M KuhnResearch and Development Service, John D. Dingell VA Medical Center, Detroit, Michigan, United States of America.ORCID 0000-0002-8546-9507
Wayne State University · US

Funding

RR&D Research Career Scientist Award ApplicationIK6RX002419 · VA · JOHN D DINGELL VA MEDICAL CENTER · PI KUHN, DONALD M · 2017 to 2023
–
ShEEP Request for an Illumina MiSeq SystemIS1BX004395 · VA · JOHN D DINGELL VA MEDICAL CENTER · PI KUHN, DONALD M · 2018 to 2018
–
BLRD VA IS1 BX004395RRD VA IK6 RX002419
6 · The paper itself

Abstract

The list of pharmacological agents that can modify the gut microbiome or be modified by it continues to grow at a high rate. The greatest amount of attention on drug-gut microbiome interactions has been directed primarily at pharmaceuticals used to treat infection, diabetes, cardiovascular conditions and cancer. By comparison, drugs of abuse and addiction, which can powerfully and chronically worsen human health, have received relatively little attention in this regard. Therefore, the main objective of this study was to characterize how selected synthetic psychoactive cathinones (aka "Bath Salts") and amphetamine stimulants modify the gut microbiome. Mice were treated with mephedrone (40 mg/kg), methcathinone (80 mg/kg), methamphetamine (5 mg/kg) or 4-methyl-methamphetamine (40 mg/kg), following a binge regimen consisting of 4 injections at 2h intervals. These drugs were selected for study because they are structural analogs that contain a β-keto substituent (methcathinone), a 4-methyl group (4-methyl-methamphetamine), both substituents (mephedrone) or neither (methamphetamine). Mice were sacrificed 1, 2 or 7 days after treatment and DNA from caecum contents was subjected to 16S rRNA sequencing. We found that all drugs caused significant time- and structure-dependent alterations in the diversity and taxonomic structure of the gut microbiome. The two phyla most changed by drug treatments were Firmicutes (methcathinone, 4-methyl-methamphetamine) and Bacteriodetes (methcathinone, 4-methyl-methamphetamine, methamphetamine, mephedrone). Across time, broad microbiome changes from the phylum to genus levels were characteristic of all drugs. The present results signify that these selected psychoactive drugs, which are thought to exert their primary effects within the CNS, can have profound effects on the gut microbiome. They also suggest new avenues of investigation into the possibility that gut-derived signals could modulate drug abuse and addiction via altered communication along the gut-brain axis.

Indexed as

AnimalsDesigner DrugsDNA, BacterialFemaleGastrointestinal MicrobiomeMethamphetamineMiceModels, AnimalPropiophenonesPsychotropic DrugsRNA, Ribosomal, 16SDesigner DrugsDNA, BacterialmephedroneMethamphetaminemonomethylpropionPropiophenonesPsychotropic DrugsRNA, Ribosomal, 16S

Identifiers

PMID31978078
PMCPMC6980639
OpenAlexW3002601159

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.